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CASE REPORTS
Transcatheter closure of recurrent aortic
pseudoaneurysm previously treated by Amplatzer
occluder device
Jamal Hussain, MD,a Robert Strumpf, MD,b Aslan Ghandforoush, DO,c Grayson Wheatley, MD,b and
John Sutherland, MD,b Phoenix, Ariz
Thoracic pseudoaneurysms are a rare variety of aortic disorders that are potentially fatal. Traditionally, these are treated
surgically. False aneurysms are usually a late complication of a previous surgical procedure. Surgical management is often
complicated by poor outcomes with high morbidity and mortality. We report a patient with recurrence of an aortic
pseudoaneurysm after closure with an Amplatzer (AGA Medical Corp, Plymouth, NH) septal occluder that was
successfully treated with a second Amplatzer device. ( J Vasc Surg 2010;52:196-8.)Thoracic pseudoaneurysms are a rare variety of aortic
disorders, and although mostly asymptomatic, they repre-
sent a potentially fatal condition. Traditionally, these are
treated surgically. False aneurysms of the aorta are usually a
late complication of previous surgical procedures, especially
reconstructive surgery, trauma, and rarely, infection. Sur-
gical management is often complicated by poor outcomes
with high morbidity and mortality.1 Our center and others
have previously published case series of transcatheter clo-
sure of aortic pseudoaneurysms with an Amplatzer device
(AGA Medical Corp, Plymouth, NH).2,3 We report a pa-
tient with recurrence of aortic pseudoaneurysm after closure
with an Amplatzer septal occluder that was successfully treated
with a second Amplatzer device.
CASE REPORT
A 69-year-old man had a history of traumatic aortic aneurysm
and underwent a repair of Stanford type A for aortic dissection in
January 2007. An aortic pseudoaneurysm subsequently developed
at the proximal suture anastomotic site after a fall. He underwent
successful endovascular repair of the expanding pseudoaneurysm
with a 12-mm Amplatzer cribriform septal occluder device in
January 2008.
A follow-up computed tomography (CT) scan in November
2008 showed a recurrence of the partially thrombosed pseudoan-
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196eurysm. The entry point was proximal to the previously deployed
Amplatzer device. The maximum aortic diameter was 7.5  8.8
mm, and a decision was made to consider transcatheter treatment
(Fig 1) owing to the patient’s previous open repair that led to
pseudoaneurysm development that was treated percutaneously.
The recurrent pseudoaneurysm appeared to be amenable to per-
cutaneous treatment. Options were discussed with the patient, and
transcatheter treatment was chosen.
The procedure was performed under general anesthesia.
Right femoral access was obtained with a 9F introducer sheath.
A transesophageal echocardiogram (TEE) probe was inserted to
identify the defect along the proximal suture lines. TEE and
intravascular ultrasound (IVUS) were used during procedure to
better guide the procedure and because this is a somewhat
innovative approach and fluoroscopy does not provide anatomic
details of the structures.
An ascending aortic angiography performed with a pigtail
catheter showed a subtle takeoff of the defect, and multiple angio-
grams were performed to best illustrate the angle of the takeoff of
the defect (Fig 2, A). The catheter was exchanged for a stiff
Lunderquist wire (Cook Medical, Bloomington, Ind), and IVUS
with a Volcano catheter (Boston Scientific, Natick, Mass) of the
ascending aorta identified the lesion to be medial and proximal to
the prior Amplatzer device.
The defect was cannulated from the right femoral artery with
4F Judkin catheters. An angiogram of the pseudoaneurysm sac was
performed. Then the right Judkin catheter was exchanged with
stiff Supracore wire (Abbott Vascular, Abbott Park, Ill), and a
shuttle sheath was advanced. We encountered resistance while
crossing the lesion with the shuttle sheath; therefore, the shuttle
sheath was removed and balloon angioplasty of the defect was
performed with a 2- 6-mm balloon. We decided to use the 6-mm
balloon after resistance was encountered when the shuttle sheath
was advanced through the defect. We were then able to advance
the shuttle sheath into the cavity.
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form 18-mm septal occluder was advanced and deployed. An
angiogram of the ascending aorta with a pigtail catheter was
Fig. 1. Recurrence of the pseudoaneurysm above the previous
Amplatzer device is shown in (A) a volumetric 3-dimensional
computed tomography (CT) image and in (B) CT angiography
left anterior oblique and (C) transverse views.performed through the contralateral femoral artery before thedevice was released (Fig 2, B) demonstrated good seal of the
defect, and the device was released from the delivery cable. An
Angio-Seal closure device (St. Jude Medical, St Paul, Minn) was
Fig 2. Conventional fluoroscopic angiographic views are shown
(A) before deployment and (B) after deployment of the second
Amplatzer device.used to close the femoral artery puncture sites.
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to assess for success of the procedure revealed a well-sealed entry
point of the pseudoaneurysm (Fig 3).
DISCUSSION
Our case demonstrates the feasibility of repeated endo-
vascular closure of aortic pseudoaneurysms. Amplatzer de-
vices are increasingly used for transcatheter treatment of
congenital and acquired structural heart disease. Current
usage includes atrial and ventricular septal defects, patent
ductal arteriosus, patent foramen ovale, vascular malforma-
tions, and vascular pseudoaneurysms. Potential future uti-
lization of different types of Amplatzer devices include
treatment of some types of endoleaks and pseudoaneu-
rysm development after endograft implantations in tho-
racic and abdominal aortic aneurysms. These are techni-
Fig 3. Computed tomography (CT) images after deplo
devices and obliteration of flow into the new pseudoan
oblique view; and (C) CT angiogram transverse view.cally feasible and have favorable patient acceptance.Although there is no known long-term comparison of
open vs transcatheter techniques in different situations,
recurrence and hence an increased number of procedures
may be a concern with transcatheter procedures. Ongo-
ing follow-up of reported series may help answer these
questions.
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